The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
448 - If a copy deck was first developed in French, can we submit it for review in French, or would it need to be translated to English and the initial review performed on the English?
Submission Requirements/process & Timelines/eFiles
1
Posts
1
Posters
297
Views
1
Watching
